PRINCETON, N.J., Dec. 11, 2018 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2G7xjzl
Τρίτη 11 Δεκεμβρίου 2018
Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program - PRNewswire
Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program PRNewswire
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2G7xjzl
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2G7xjzl
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.